Literature DB >> 15638264

Immune cell populations in the duodenal mucosa of cats with inflammatory bowel disease.

Nashwa E Waly1, Christopher R Stokes, Timothy J Gruffydd-Jones, Michael J Day.   

Abstract

The aim of this study was to characterize the phenotype of leukocytes infiltrating the duodenal mucosa of cats with inflammatory bowel disease (IBD) by using immunohistochemistry and computer-aided morphometry to assess whether immunologic markers would aid in characterization of IBD. Frozen and formalin-fixed duodenal biopsies were collected from cats referred for investigation of chronic vomiting, diarrhea, or both (n = 34). Reference ranges were previously established by using duodenal samples from healthy cats (n = 16). No significant difference was found in the number of immunoglobulin G+ (IgG+) or IgA+ in either the villous lamina propria or the crypt lamina propria between cats with IBD and control cats. T cells (CD3+) increased in number from crypt to the tip of the villi in biopsies from both diseased (mean +/- SD for each group was 18.8 +/- 6.6 and 17.7 +/- 4.2 cells/ 10,000 m2 in cryptal areas to 25.2 +/- 9.5 and 29.1 +/- 13.3 cells/10,000m2 in villous areas) and healthy animals (17.9 +/- 3.9 cells/10,000 microm2 in cryptal areas to 24.1 +/- 9.3 cells/10,000 microm2 in villous areas) and no significant difference was found between diseased and control cats. By contrast, major histocompatibility complex (MHC) class II expression by leukocytes with dendritic cell or macrophage morphology in the lamina propria was significantly greater in cats with IBD (13.3 +/- 4.2 cells/10,000 microm2 in cryptal area; P = .016) than in healthy cats (11.9 +/- 3.0 cells/10,000 microm2) and MHC class II expression by enterocytes also was more pronounced in these cats showing an overall intensity of expression of 7.1 +/- 4.0 cells/10,000 microm2 in cats with IBD as opposed to 0.0 +/- 0.0 cells/10,000 microm2 to 0.3 +/- 0.7 cells/10,000 microm2 in healthy cats. These findings suggest that a subtle immunologic dysregulation occurs in spontaneously arising feline IBD.

Entities:  

Mesh:

Year:  2004        PMID: 15638264     DOI: 10.1892/0891-6640(2004)18<816:icpitd>2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  6 in total

1.  Pharmacokinetics of masitinib in cats.

Authors:  François Bellamy; Thomas Bader; Alain Moussy; Olivier Hermine
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

Review 2.  Cats are not small dogs: is there an immunological explanation for why cats are less affected by arthropod-borne disease than dogs?

Authors:  Michael J Day
Journal:  Parasit Vectors       Date:  2016-09-20       Impact factor: 3.876

3.  Results of histopathology, immunohistochemistry, and molecular clonality testing of small intestinal biopsy specimens from clinically healthy client-owned cats.

Authors:  Sina Marsilio; Mark R Ackermann; Jonathan A Lidbury; Jan S Suchodolski; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2019-02-28       Impact factor: 3.333

4.  Measurement of IL-12 (p40, p35), IL-23p19, and IFN-γ mRNA in duodenal biopsies of cats with inflammatory enteropathy.

Authors:  N E Waly; I R Peters; M J Day; C R Stokes; M Bailey; T J Gruffydd-Jones
Journal:  J Vet Intern Med       Date:  2013-10-21       Impact factor: 3.333

5.  Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice.

Authors:  Ju-Hyun An; Woo-Jin Song; Qiang Li; Sang-Min Kim; Ji-In Yang; Min-Ok Ryu; A Ryung Nam; Dong Ha Bhang; Yun-Chan Jung; Hwa-Young Youn
Journal:  BMC Vet Res       Date:  2018-11-20       Impact factor: 2.741

Review 6.  Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease.

Authors:  Mathieu V Paulin; Lucile Couronné; Jérémy Beguin; Sophie Le Poder; Maxence Delverdier; Marie-Odile Semin; Julie Bruneau; Nadine Cerf-Bensussan; Georgia Malamut; Christophe Cellier; Ghita Benchekroun; Laurent Tiret; Alexander J German; Olivier Hermine; Valérie Freiche
Journal:  BMC Vet Res       Date:  2018-10-11       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.